Incorporating measurable (‘minimal’) residual disease-directed treatment strategies to optimize outcomes in adults with acute myeloid leukemia
2016 ◽
Vol 57
(7)
◽
pp. 1527-1533
◽
Keyword(s):
2017 ◽
Vol 92
(9)
◽
pp. 845-850
◽
2009 ◽
Vol 21
(6)
◽
pp. 582-588
◽
Keyword(s):
2009 ◽
Vol 131
(1)
◽
pp. 16-26
◽